Reactivation of pemphigus by varicella zoster virus after anti-CD20 treatment

Int J Dermatol. 2020 Mar;59(3):e52-e53. doi: 10.1111/ijd.14711. Epub 2019 Dec 15.

Authors

Pierre-Antoine Douard¹, Stephanie Delaumenie¹, Julien Pittoni¹, Safae Assikar¹, Ioana Matei¹, Romain Prudhomme¹, Damien Audevard¹, Christophe Bédane¹

Affiliation

¹ National Reference Center for Bullous Diseases, Department of Dermatology, Hopital Dupuytren 2, Limoges, France.

PMID: 31840226
DOI: 10.1111/ijd.14711

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antigens, CD20 / immunology
Glucocorticoids / therapeutic use
Herpes Zoster / complications
Herpes Zoster / diagnosis
Herpes Zoster / drug therapy
Herpes Zoster / immunology*
Herpesvirus 3, Human / immunology*
Herpesvirus 3, Human / isolation & purification
Humans
Immunologic Factors / adverse effects*
Male
Pemphigus / diagnosis
Pemphigus / drug therapy
Pemphigus / immunology*
Recurrence
Rituximab / adverse effects*
Valacyclovir / therapeutic use
Virus Activation / drug effects
Virus Activation / immunology*

Substances

Antigens, CD20
Glucocorticoids
Immunologic Factors
Rituximab
Valacyclovir